Emerging Applications of Nanobiotechnology and Nanomedicine

slide1 n.w
1 / 43
Embed
Share

Explore the diverse applications of nanobiotechnology and nanomedicine, including the development of biosensors utilizing nanoparticles and nanostructured materials to enhance sensitivity in detecting biological signals. Discover how these advancements are revolutionizing healthcare with rapid growth driven by the need for accurate and efficient diagnostic tools.

  • Nanobiotechnology
  • Nanomedicine
  • Biosensors
  • Nanoparticles
  • Nanostructured Materials

Uploaded on | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. Applications of Nanobiotechnology & nanomedicine

  2. NANOBIOSENSORS

  3. What are biosensors? A biosensor is an analytical device which converts response into an electrical signal (Figure 6.1). a biological

  4. biological systems may be utilised by biosensors, for example, whole cell metabolism, ligand binding and the antibody-antigen reaction.

  5. Biosensors represent a rapidly expanding field, at the present time, with an estimated 60% annual growth rate; the major impetus coming from the health-care industry (e.g. 6% of the western world are diabetic and would benefit from the availability of a rapid, accurate and simple biosensor for glucose)

  6. In recent years, a wide varietyof nanoparticles with different properties, such as small size, high speeds, smaller distances for electrons to travel, lower power, and lower voltages Important advances in the field of nanotechnology have led to the utilization of nanomaterials such as metal nanoparticles, nanoparticles,magnetic nanomaterials, carbon materials oxide

  7. Functional nanoparticles that bound to biological molecules (e.g. peptides, proteins, nucleic acids) have been developed for use in biosensors to detect and amplyfi various signals.

  8. NANOSTRUCTURED MATERIALS FOR BIOSENSING DEVICES Nano structuredmaterials are interesting tools with specific physical and chemical properties because of their quantum-size effects when compared to bulk materials The exploration characteristics provides the possibility to improve the sensitivity of biosensors of these different

  9. These nanostructured materials with specific forms like quantum dots nanoparticles (0D), Nanowires and carbon nanotubes (1D), and metallic platelets These devices offer improved sensitivities, due to their large surface-to-volume ratios, include the utilization of .

  10. NANOPARTICLES-BASED BIOSENSORS Metallic nanoparticles are very interesting materials with unique electronic and electrocatalytic depending on their size and morphology Nanoparticle-based biosensors are particularly properties

  11. Nanoparticle-based biosensors are - Particularly attractive because they can be easily synthesized in bulk using standard chemical techniques, -do not require advanced fabrication approaches. - They also offer particularly high surface areas due to their extremely small size and are typically used as suspensions in solutions (during the time when they interact with the analyse).

  12. Most biological molecules can be labelled withmetal nanoparticleswithout compromising their biological activities [22]. In particular, gold nanoparticles are much explored materials as components for biosensors, due to their capability to increase an electronic signal when a biological component is maintained in contact with its nanostructured surface [23].

  13. The materials has provided new paths for enzymatic biosensor development. exploration of gold nanostructured

  14. This observationis especially useful in the development of electroluminescence- based biosensors . Apart from gold, silver, platinum, palladium, copper, cobalt and other nanoparticles are also extensively explored in the development of biosensors

  15. The research on nanobioelectronics & biosensors aims at the integration of nanoelectronics, tools and materials into lowcost, user friendly -interest in several fields such as diagnostics, food analysis, environmentmonitoring and other industries.

  16. Functionalization of nanoparticles using small molecule ligands A wide variety of ligands have been incorporated onto nanoparticle to be used in intracellular delivery. nanoparticles functionalized diseases, and surfaces For example, diagnosis of .

  17. Nanotechnology plays an important role in advanced biology and particularly in the development of potential site specific delivery systems with lower drug toxicities greater efficiencies.[5] medical research

  18. The era of nanotechnology has allowed novel research strategies to flourish in the field of drug delivery. Nanotechnology designed drug delivery systems have been seen to be suitable for treating chronic intracellular infections.

  19. Recent progress in cancer nanotechnology gives rise to exciting opportunities in which diagnosis and treatment are based on the molecular profiles of individual patients.

  20. Nanotechnology" was first defined by Tokyo Science University, Norio Taniguchi in 1974. Although the application of nanotechnology to medicine appears to be a relatively recent trend, the basic nanotechnology approaches for medical application dates back to several decades.

  21. Lipid vesicles which were named as liposomes, were described in 1965, in 1976 the description about the first controlled release polymer system of macromolecules was given, the first quantum dot bioconjugate was described in 1998, nanosenser was and the first nanowire described in 2001. liposomes quantum dot bioconjugate polymer system of macromolecules nanowire nanosenser

  22. One of the major applications of nanotechnology in relation to medicine is drug delivery. The problems with the new chemical entities such as insolubility, degradation, bioavailability, toxicologic effects, targeted drug delivery, and controlled drug release are solved by nanotechnology.

  23. For example, encapsulated drugs can be protectedfrom degradation. Specific nanosized receptors present on the surface of the cell can recognize the drug and elicit appropriate response by delivering and releasing the therapy exactly wherever needed

  24. . Because of their small size and large surface area relative to their volume,

  25. nanoscale devices can readily interact with biomolecules. Nanoscale devices nanoparticles [Figure cantilevers, semiconductor nanocrystals, and liposomes. include: nanotubes, 1],

  26. Nanotubes Nanotubes are smaller than nanopores [Figure 2]. Nanotubes help Dioxyribonucleic acid associated with cancer cells. They are about half the molecule of DNA. It helps to exactly pin point location of the changes. to identify changes (DNA) diameter of a

  27. physical shape of the DNA can be traced with the help of the nano tube tip. A computer translates the information into topographical map.

  28. The bulky molecules identify the regions on the map where mutations are present. Since the location of mutations can influence the effects they have on a cell, these techniques are important in predicting disease

  29. Quantum dotes These are tiny crystals that glow when these are stimulated by ultraviolet light [Figure 3]. The latex beads filled with these crystals when stimulated by light, emit the color that lights up the sequence of interest.

  30. When the crystals are stimulated by light, the colors they emit serve as dyes and light up the sequences of interest

  31. Antibody conjugated quantum dotes[39]

  32. Nanoshells Nanoshells (NS) are gold coated miniscule beads [Figure 4]. The wavelength of light related to the thickness of the coatings. Thus, by manipulating the thickness of the layers making up the NS, the beads can be designed that absorb specific wavelength of light. which the beads absorb is

  33. The most useful NS are those that absorb near infrared light that can easily penetrate several centimeters Absorption of light by NS creates an intense heat that is lethal to cells. Metal NS which are intense near-infrared absorbers are effective both in-vivo and in- vitro on human breast carcinoma cells. in human tissues.

  34. Nanoshells

  35. Liposomes Liposomes structures composed of lipid bilayers that surround a central aqueous space. Liposomal formulations have shown an ability to improve the pharmacokinetics pharmacodynamics Liposome based formulations of several anticancer agents have been approved for the treatment of metastatic breast cancer and Kaposi's sarcoma. spherical, closed colloidal and of associated drugs.

  36. Cantilevers Tiny bars anchored at one end can be engineered to bind to molecules associated with cancer [Figure 5]. These molecules may bind to altered DNA proteins that are present in certain types of cancer monitoring cantilevers; it would be possible to tell whether the cancer molecules are present and hence detect early molecular events in the development of cancer cells the bending of

  37. Nanocantilever array[26]

  38. Dendrimers Dendrimers are new class of macromolecules which have a symmetric core and form the 3- D spherical structure [Figure 6]. These have branching shape which gives them vast amounts of surface area to which therapeutic agents or other biologically active molecules can be attached.

  39. A single dendrimer can carry a molecule that recognizes cancer cells, a therapeutic agent to kill those cells, and a molecule that recognizes the signals of cell death. It is said that dendrimers can be manipulated to release their contents only in the presence of certain trigger molecules associated with cancer

  40. Dendrimer[41]

  41. Thanks for your attention

More Related Content